“…To transport these therapeutic molecules into target cells and tissues, scientists have devised a number of nanocarriers, such as nanoparticles and DNA nanostructures . Framework nucleic acids (FNAs), a wide variety of robust DNA nanoframes (for example, tetrahedrons, pyramids, and cubes), display unique biophysical and biochemical properties, and have proven ideal nanocarriers for intracellular transport of molecular payloads, including proteins, anticancer drugs, siRNAs, and ASOs . However, the activation of the FNA nanocarriers in vivo for controllable cargo release once they enter cells remains a challenge.…”